-
Dyax Announces FDA Approval of Kalbitor (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema in Patients 16 Years of Age and Older - 2 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 1, 2009 - Dyax Corp. announced today that the U.S. Food and...
-
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause - 2 days ago
PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and...
-
FDA Approves OTC Version Of Heartburn Drug Zegerid - 2 days ago
WHITEHOUSE STATION, N.J.--Merck & Co. and Santarus Inc. said Tuesday the Food and Drug...
RSS